Kaia Health is a digital therapeutics company founded in 2016 by Konstantin Mehl and Manuel Thurner, with headquarters in Munich, Germany and New York City. It develops smartphone-based digital therapy programs that use computer vision to deliver real-time exercise feedback, based on multimodal therapy combining physical exercise, mind-body support and pain education. Its products include Kaia MSK for back, joint and chronic pain, Kaia Breathe for pulmonary rehabilitation in chronic obstructive pulmonary disease (COPD), and a digital pelvic floor program.

The company sells primarily to employers, health plans and health systems, mainly in the United States and Europe. Its German digital health application Kaia Rückenschmerzen was listed as a DiGA reimbursed by statutory health insurance. The company holds ISO 13485 certification and is GDPR and HIPAA compliant. Partners have included Optum, WebMD Health Services, DKV and Ramp Health.

Kaia Health raised more than $125 million across its funding rounds, including a $75 million Series C in April 2021. In January 2026 the company was acquired by Sword Health in a cash and share deal valued at up to $285 million, and it now operates as part of Sword Health.